Enso Ventures backs Galera Therapeutics
Malvern, Pennsylvania-based Galera Therapeutics, a developer of new treatments for cancer patients, has secured $5 million in funding from Enso Ventures. This capital infusion brings Galera's Series B funding total to $42 million. Galera's other investors are New Enterprise Associates, Novartis Venture Fund, Novo Ventures, Correlation Ventures and Galera Angels.
3 February 2016•3 mins read
